Clinical Trials Browser

Solid Tumor Cancer × Imatinib Mesylate × Clear all

NCT06962254 2025-05-08

Imatinib and Trametinib for KRAS-mutated Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor Cancer